AI Capital Spending Boom Rivals Historical Investment Explosions Raymond James Analysts Say Kevin Warshs Potential Fed Shift Could Reshape Wall Streets Market Plumbing Silver Prices Slide on Wednesday Morning Amid Dollar Strength and Rate Concerns Princeton CorpGov Forum Examines SpaceX and Private vs Public Capital Market Dynamics Novartis Lifts FullYear Sales and Profit Outlook Amid Strong Operational Performance Deere Company Raises FullYear Outlook Citing AIPowered Growth Lever in Precision Agriculture GRNT Q1 2026 Earnings EPS Misses Estimates by Over 80 ALEC Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Market Response ESOA Q1 2026 Earnings EPS Surges Past Estimates with 743 Surprise Lyell Immunopharma Q1 2026 Earnings Narrower Loss Beats Estimates as Pipeline Progress Continues Constellium SE Q1 2026 Earnings Stunning EPS Surge Signals Strong Operational Leverage AREC Q3 2025 Earnings NarrowerthanExpected Loss Drives Positive Sentiment Tivic Health Systems TIVC Holds Steady at 140 as Key Support and Resistance Levels Define Range Novavax NVAX Surges 136 Momentum Builds Above Key Support VLYPN Preferred Stock Maintains Stability Amid Modest Decline Valley National Bancorp Preferred Stock VLYPO Holds Steady Near 2512 Key Support and Resistance in Focus Perdoceo Education PRDO Slips Slightly as Shares Approach Support Zone Bond SellOff Raises Specter of Vigilante Intervention SKYE Q1 2026 Earnings EPS Misses Estimates Amid No Revenue Shares Edge Higher Seabridge Gold SA Holds Steady Above 30 as Gold Sentiment Supports Gains Insulet Corporation PODD Q1 2026 Earnings EPS Surges Past Estimates Despite Slight Stock Pullback PAYC Q1 2026 Earnings EPS Beat Drives Cautious Sentiment DGICB Q1 2026 Earnings Earnings Miss Estimates as EPS Falls Short of Expectations OKTA Q1 2026 Earnings EPS Beat Drives Positive Market Reaction VersaBank VBNK Q1 2026 Earnings EPS Miss Amid Challenging Quarter PHUN Q1 2026 Earnings EPS Beats Estimates Amid Limited Revenue Disclosure PRME Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline